We further investigated TC2N expression patterns with respect to tumor stages, tumour grades, histological subtypes, nodal metastasis and other clinical parameters only in those 9 tumours which showed significant differential expression of TC2N (i.e, CHOL, OV, READ, STAD, THYM, PCPG, SKCM, THCA and UCS). This evidence concerns the gene TC2N and neoplasm.